Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Dare Bioscience (DARE) Accumulated Depreciation & Amortization (2016 - 2025)

Dare Bioscience's Accumulated Depreciation & Amortization history spans 8 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 3761.75% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, up 3761.75%, while the annual FY2025 figure was $1.6 million, 3761.75% up from the prior year.
  • Accumulated Depreciation & Amortization reached $1.6 million in Q4 2025 per DARE's latest filing, up from $42325.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.6 million in Q4 2025 to a low of $42325.0 in Q4 2024.
  • Average Accumulated Depreciation & Amortization over 3 years is $607504.3, with a median of $145702.0 recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: tumbled 70.95% in 2024, then skyrocketed 3761.75% in 2025.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $145702.0 in 2023, then crashed by 70.95% to $42325.0 in 2024, then surged by 3761.75% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Accumulated Depreciation & Amortization are $1.6 million (Q4 2025), $42325.0 (Q4 2024), and $145702.0 (Q4 2023).